Parecoxib
- Generic Name
- Parecoxib
- Brand Names
- Dynastat
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18N2O4S
- CAS Number
- 198470-84-7
- Unique Ingredient Identifier
- 9TUW81Y3CE
- Background
Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of E...
- Indication
Used for short term perioperative pain control.
- Associated Conditions
- Postoperative pain
- Associated Therapies
- -
Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain
- First Posted Date
- 2010-10-14
- Last Posted Date
- 2011-03-25
- Target Recruit Count
- 900
- Registration Number
- NCT01221025
- Locations
- 🇨🇳
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Parecoxib in Renal Colic
Phase 3
Terminated
- Conditions
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 50
- Registration Number
- NCT00139646
- Locations
- 🇮🇹
Pfizer Investigational Site, Siena, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath